Market Performance Analysis
Novartis (NVS) concluded the latest trading session at $95.92, marking a -1.39% decline from the previous day. This performance lagged behind the S&P 500, which saw a daily upturn of 0.63%. Simultaneously, the Dow edged up by 0.2%, while the Nasdaq surged by 0.82%.
Stock Trend Assessment
Over the past month, the pharmaceutical giant’s stock has fallen by 2.91%, falling short of the Medical sector’s 0.91% increase and the S&P 500’s 1.76% climb.
Earnings and Revenue Projections
Analysts and investors are poised to monitor Novartis closely during its upcoming earnings announcement. Predictions point to an EPS of $1.73, reflecting a 1.17% incline from the prior year’s equivalent quarter. Revenue estimates stand at $11.43 billion, suggesting an 11.75% dip from the corresponding period last year.
Zacks Consensus Estimates for the entire year anticipate earnings of $7.18 per share and revenue of $47.44 billion, translating to changes of +4.06% and -4.69%, respectively, compared to the previous year.
Zacks Rank and Valuation Metrics
Novartis’ Zacks Rank currently holds at #3 (Hold), with the Zacks Consensus EPS estimate decreasing by 0.69% in the past month. The company’s Forward P/E ratio of 13.56 suggests it may be trading at a discount relative to its industry average.
Moreover, the PEG ratio of NVS stands at 1.51, indicating a favorable position compared to the Large Cap Pharmaceuticals industry average of 1.72. This industry, nestled within the Medical sector, ranks at 191 out of over 250 industries, placing it in the bottom quartile.
Industry Performance and Insights
The Large Cap Pharmaceuticals industry’s Zacks Industry Rank, currently at 191, places it amongst the lower 25% of all industries. The superior performance of industry groups with higher Zacks Industry Ranks underscores the importance of staying abreast of these metrics for strategic investment decisions.
For the latest stock-influencing details and more, be sure to utilize Zacks.com for continuous market updates.
Intrigued by Infrastructure Investments?
A massive infrastructure revitalization effort in the United States is on the horizon, promising tremendous opportunities for growth. Stay ahead of the curve – download Zacks’ Special Report for insights on five companies poised to benefit from the forthcoming construction projects and energy transformations.
Disclaimer: The views contained in this article are solely the author’s and do not necessarily reflect the opinions of Nasdaq, Inc.
